U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Drugs
  3. Development & Approval Process | Drugs
  4. Development Resources
  5. Kanamycin – Injection Products
  1. Development Resources

Kanamycin – Injection Products

Recognized Interpretive Criteria
Additional FDA-identified interpretive criteria

 

Minimum Inhibitory
Concentrations

(mcg/mL)

Disk Diffusion
(zone diameter in mm)

Pathogen

S

I

R

S

I

R

Enterobacterales

M100 standard is recognized

Staphylococcus aureus

≤ 16

32

≥ 64

≥ 18

14-17

≤ 13

S = Susceptible; I = Intermediate; R = Resistant

Back to Top